Ildong Holdings Co., Ltd. (000230.KS)
KRW 6600.0
(-5.44%)
KRW 6600.0
(-5.44%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 91.16 Billion KRW | -13.39% |
| 2022 | 105.25 Billion KRW | 16.07% |
| 2021 | 90.68 Billion KRW | -6.26% |
| 2020 | 96.74 Billion KRW | 23.98% |
| 2019 | 78.02 Billion KRW | 1314.38% |
| 2018 | 5.51 Billion KRW | 2.65% |
| 2017 | 5.37 Billion KRW | 8.93% |
| 2016 | 4.93 Billion KRW | -93.52% |
| 2015 | 76.14 Billion KRW | -2.03% |
| 2014 | 77.72 Billion KRW | 30.15% |
| 2013 | 59.72 Billion KRW | 6.68% |
| 2012 | 55.98 Billion KRW | 16.61% |
| 2011 | 48 Billion KRW | -21.36% |
| 2010 | 61.05 Billion KRW | 29.05% |
| 2009 | 47.3 Billion KRW | -18.32% |
| 2008 | 57.91 Billion KRW | 20.15% |
| 2007 | 48.2 Billion KRW | 26.73% |
| 2006 | 38.03 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 90.67 Billion KRW | -0.54% |
| 2024 Q2 | 97.99 Billion KRW | 8.07% |
| 2023 Q4 | 91.16 Billion KRW | -4.89% |
| 2023 Q1 | 113.41 Billion KRW | 7.75% |
| 2023 Q2 | 113.79 Billion KRW | 0.34% |
| 2023 FY | 91.16 Billion KRW | -13.39% |
| 2023 Q3 | 95.84 Billion KRW | -15.77% |
| 2022 Q3 | 107 Billion KRW | -3.65% |
| 2022 Q1 | 104.81 Billion KRW | 15.58% |
| 2022 FY | 105.25 Billion KRW | 16.07% |
| 2022 Q4 | 105.25 Billion KRW | -1.64% |
| 2022 Q2 | 111.06 Billion KRW | 5.96% |
| 2021 Q1 | 96.83 Billion KRW | 0.09% |
| 2021 FY | 90.68 Billion KRW | -6.26% |
| 2021 Q4 | 90.68 Billion KRW | -5.52% |
| 2021 Q3 | 95.98 Billion KRW | -3.61% |
| 2021 Q2 | 99.58 Billion KRW | 2.85% |
| 2020 Q2 | 93.17 Billion KRW | 13.63% |
| 2020 Q1 | 81.99 Billion KRW | 5.08% |
| 2020 FY | 96.74 Billion KRW | 23.98% |
| 2020 Q3 | 99.3 Billion KRW | 6.59% |
| 2020 Q4 | 96.74 Billion KRW | -2.58% |
| 2019 FY | 78.02 Billion KRW | 1314.38% |
| 2019 Q4 | 78.02 Billion KRW | -3.37% |
| 2019 Q2 | 5.71 Billion KRW | 0.67% |
| 2019 Q1 | 5.68 Billion KRW | 2.97% |
| 2019 Q3 | 80.74 Billion KRW | 1311.94% |
| 2018 Q2 | 6.39 Billion KRW | 18.09% |
| 2018 Q1 | 5.41 Billion KRW | 0.74% |
| 2018 FY | 5.51 Billion KRW | 2.65% |
| 2018 Q4 | 5.51 Billion KRW | -14.87% |
| 2018 Q3 | 6.48 Billion KRW | 1.37% |
| 2017 Q4 | 5.37 Billion KRW | 4.46% |
| 2017 FY | 5.37 Billion KRW | 8.93% |
| 2017 Q1 | 5.29 Billion KRW | 7.29% |
| 2017 Q2 | 5.07 Billion KRW | -4.17% |
| 2017 Q3 | 5.14 Billion KRW | 1.43% |
| 2016 Q1 | 69.99 Billion KRW | -8.08% |
| 2016 Q4 | 4.93 Billion KRW | 15.75% |
| 2016 Q3 | 4.26 Billion KRW | 5.39% |
| 2016 Q2 | 4.04 Billion KRW | -94.22% |
| 2016 FY | 4.93 Billion KRW | -93.52% |
| 2015 Q4 | 76.14 Billion KRW | -5.69% |
| 2015 FY | 76.14 Billion KRW | -2.03% |
| 2015 Q3 | 80.74 Billion KRW | 0.44% |
| 2015 Q2 | 80.39 Billion KRW | 8.69% |
| 2015 Q1 | 73.96 Billion KRW | -4.84% |
| 2014 FY | 77.72 Billion KRW | 30.15% |
| 2014 Q4 | 77.72 Billion KRW | 11.32% |
| 2014 Q3 | 69.82 Billion KRW | 9.84% |
| 2014 Q2 | 63.56 Billion KRW | 2.12% |
| 2014 Q1 | 62.24 Billion KRW | 4.23% |
| 2013 Q4 | 59.72 Billion KRW | 5.81% |
| 2013 FY | 59.72 Billion KRW | 6.68% |
| 2013 Q3 | 56.44 Billion KRW | -15.54% |
| 2013 Q1 | 63.16 Billion KRW | 12.83% |
| 2013 Q2 | 66.82 Billion KRW | 5.79% |
| 2012 FY | 55.98 Billion KRW | 16.61% |
| 2012 Q4 | 55.98 Billion KRW | 0.0% |
| 2012 Q1 | 48.2 Billion KRW | 0.0% |
| 2011 Q1 | 40.11 Billion KRW | 0.0% |
| 2011 Q2 | 41.93 Billion KRW | 4.54% |
| 2011 Q3 | 44.63 Billion KRW | 6.44% |
| 2011 FY | 48 Billion KRW | -21.36% |
| 2010 Q2 | 37.16 Billion KRW | 0.0% |
| 2010 Q3 | 37.51 Billion KRW | 0.94% |
| 2010 FY | 61.05 Billion KRW | 29.05% |
| 2009 Q4 | 42.67 Billion KRW | 22.19% |
| 2009 Q3 | 34.92 Billion KRW | -0.61% |
| 2009 FY | 47.3 Billion KRW | -18.32% |
| 2009 Q2 | 35.13 Billion KRW | 0.0% |
| 2008 Q4 | 37.19 Billion KRW | 15.81% |
| 2008 Q2 | 33.15 Billion KRW | 0.0% |
| 2008 Q3 | 32.11 Billion KRW | -3.12% |
| 2008 FY | 57.91 Billion KRW | 20.15% |
| 2007 FY | 48.2 Billion KRW | 26.73% |
| 2007 Q2 | 26.88 Billion KRW | 0.0% |
| 2007 Q4 | 27.97 Billion KRW | 2.7% |
| 2007 Q3 | 27.24 Billion KRW | 1.34% |
| 2006 FY | 38.03 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -106.482% |
| Dong-A Socio Holdings Co., Ltd. | 117.85 Billion KRW | 22.644% |
| HANDOK Inc. | 94.46 Billion KRW | 3.491% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -329.157% |
| Yuhan Corporation | 284.75 Billion KRW | 67.985% |
| Dong-A ST Co., Ltd. | 116.31 Billion KRW | 21.62% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -460.724% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 68.434% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -181.515% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -47.698% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -368.07% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -201.075% |
| Hana Pharm Co., Ltd. | 48.34 Billion KRW | -88.565% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -106.482% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -191.818% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -159.169% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -89.424% |
| JW Holdings Corporation | 147.58 Billion KRW | 38.23% |
| Ildong Pharmaceutical Co., Ltd. | 84.62 Billion KRW | -7.732% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | 65.128% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 14.068% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -69.067% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -237.678% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -180.413% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | 16.946% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -106.482% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | 51.673% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | 62.257% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 14.068% |
| Yuhan Corporation | 284.75 Billion KRW | 67.985% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | 27.23% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | -47.074% |
| Suheung Co., Ltd. | 259.84 Billion KRW | 64.915% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 14.068% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | -14.527% |
| Korea United Pharm Inc. | 49.14 Billion KRW | -85.516% |
| CKD Bio Corp. | 69.08 Billion KRW | -31.968% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | 13.239% |
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | -28.953% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | -68.646% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -69.067% |
| Chong Kun Dang Holdings Corp. | 194.76 Billion KRW | 53.192% |
| Boryung Corporation | 189.8 Billion KRW | 51.969% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | -60.414% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -47.698% |
| JW Lifescience Corporation | 23.39 Billion KRW | -289.623% |